Prevalence of current tobacco use in Türkiye
Türkiye: Prevalence of current tobacco use was 31.1% in 2024. ▼ Falling
Prevalence of current tobacco use in Türkiye, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of adults.
Analysis
Türkiye recorded 31.1% for prevalence of current tobacco use in 2024. That is the lowest value across all 9 years on record.
Compared with earlier readings it is down 1.3% over ten years.
Over the whole period, prevalence of current tobacco use in Türkiye peaked at 32.8% in 2000 and was at its lowest, 31.1%, in 2022.
That places Türkiye 25th out of 166 countries with data for 2024, putting it in the top quarter.
Prevalence of current tobacco use in Türkiye, year by year
| Year | % of adults | Change |
|---|---|---|
| 2000 | 32.8% | — |
| 2005 | 32.3% | -1.5% |
| 2007 | 31.9% | -1.2% |
| 2010 | 31.8% | -0.3% |
| 2015 | 31.5% | -0.9% |
| 2020 | 31.2% | -1.0% |
| 2022 | 31.1% | -0.3% |
| 2023 | 31.1% | +0.0% |
| 2024 | 31.1% | +0.0% |
Türkiye compared with similar countries
- Türkiye's 31.1% is above the median for upper middle income countries, which is 21.1%, 1.5× the median. (51 countries reporting)
- Türkiye's 31.1% is above the median for Europe & Central Asia, which is 26.1%, 1.2× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.3% | 31.9% | 32.8% | 3 |
| 2010s | 31.6% | 31.5% | 31.8% | 2 |
| 2020s | 31.1% | 31.1% | 31.2% | 4 |
Countries ranked near Türkiye
More health data for Türkiye
- Un projection of annual infant deaths, annual growth rate -1.72 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5275 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,582 deaths per 1,000 people (2090)
- Number of infants who die before age 1 858 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2025)
- Population ages 00-04, female, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0298 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.94 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is prevalence of current tobacco use in Türkiye?
- Prevalence of current tobacco use in Türkiye was 31.1% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use recorded in Türkiye?
- The highest recorded value was 32.8% in 2000.
- What is the lowest prevalence of current tobacco use recorded in Türkiye?
- The lowest recorded value was 31.1% in 2022.
- How does Türkiye rank for prevalence of current tobacco use?
- Türkiye ranks 25th out of 166 countries with data for 2024.
- Is prevalence of current tobacco use rising or falling in Türkiye?
- Over the last ten years it is down 1.3%. The long-run trend across the full record is falling.
- Where does this Türkiye data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use (% of adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.